Safety, reactogenicity, and immunogenicity of a 12-valent pneumococcal non-typeable <i>Haemophilus influenzae</i> protein D-conjugate vaccine in healthy toddlers: results from a phase I, randomized trial
Human vaccines & immunotherapeutics